Ibuprofen Detailed Renal, GI Warnings Required For Monograph Inclusion
This article was originally published in The Tan Sheet
Executive Summary
Clinical study data and adverse event reports support inclusion of a warning on OTC ibuprofen labeling to alert consumers at risk for developing acute renal failure to consult a doctor, FDA says